Flowcytometric DNA ploidy pattern for predicting metastasis of clinical stage I nonseminomatous germ cell testicular tumors
- 30 April 1993
- Vol. 41 (4) , 379-383
- https://doi.org/10.1016/0090-4295(93)90604-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Identifying patients with low risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillanceUrology, 1989
- Clinical stage i nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy aloneCancer, 1988
- Flow cytometry derived DNA content of the primary lesions of advanced germ cell tumoursInternational Journal of Andrology, 1987
- Nonseminomatous Germ Cell Tumor of the Testicle: Does Extensive Staging of the Primary Tumor Predict the Likelihood of Metastatic Disease?Journal of Urology, 1986
- Prognostic Factors in Non Semin Omatous Testicular CancerJournal of Urology, 1986
- Selection of Testicular Tumor Patients for Omission of retroperitoneal Lymph Node DissectionJournal of Urology, 1986
- DNA flow cytometry in human testicular cancerCancer Letters, 1985
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983
- Retroperitoneal LymphadenectomyUrologic Clinics of North America, 1977
- Non-Seminomatous Testis Tumors: a Plan of Management Based on 96 Patients to Improve Survival in All Stages by Combined Therapeutic ModalitiesJournal of Urology, 1976